Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NASDAQ:GCVRZ)

0.44
Delayed Data
As of Mar 24
 0.00 / 0.00%
Today’s Change
0.09
Today|||52-Week Range
0.50
+15.79%
Year-to-Date
How I'd Play Biotech Buyout Rumors
Mar 24 / TheStreet.com - Paid Partner Content
Merck Closes Acquisition of Controlling Stake in Vallee S.A
Mar 23 / Zacks.com - Paid Partner Content
How I'd Play Biotech Buyout Rumours
Mar 24 / TheStreet.com - Paid Partner Content
Will Sanofi (SNY) Prove to be a Suitable Value Stock?
Mar 22 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Is Sanofi Buying Flexion? Pfizer, Merck KGaA Drug Approved
Mar 24 / Zacks.com - Paid Partner Content
Amgen (AMGN): Repatha Outcomes Data Disappoint, Shares Drop
Mar 20 / Zacks.com - Paid Partner Content
Flexion (FLXN) Stock Soars 35% on $1 Billion Sanofi Buyout
Mar 23 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: U.S. Bancorp, Verizon, EOG Resources, Sanofi and N...
Mar 17 / Zacks.com - Paid Partner Content
Sanofi Said to Be Near $1 Billion Deal for Flexion
Mar 23 / TheStreet.com - Paid Partner Content
What are Sanofi's (SNY) Strengths and Challenges in 2017?
Mar 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close0.44
Today’s open0.43
Day’s range0.43 - 0.44
Volume3,853
Average volume (3 months)467,971
Market cap--
Dividend yield--
Data as of 2:04pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)--
Annual profit (last year)--
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
--, --

Forecasts


Search for Jobs